A look back at Philly-area businesses that didn’t survive 2025

Rite Aid filed its second bankruptcy in under two years and announced the closure or sale of all ~1,000 stores (about 100 in the Philadelphia region), shuttering all Pennsylvania and New Jersey locations by late August and displacing thousands of workers while redirecting prescriptions to CVS, Walgreens or local pharmacies. Iron Hill Brewery abruptly closed nearly 30 years of operations, reporting more than $20 million owed to creditors and roughly $125,000 in the bank, with a judge approving a bid to revive up to 10 locations pending landlord negotiations; several other long-running local operators — including Maxwell Taxi, the Bistro at Cherry Hill (converted to Chapter 7) and Macy’s locations — also ceased operations, highlighting stressed regional retail, restaurant and leisure sectors and potential creditor/landlord recoveries.

Analysis

Market structure: Rite Aid's exit (~1,000 stores nationally; ~100 in Philly) is a direct volume transfer opportunity for big pharmacies—CVS (CVS) is best positioned to capture 0.5–1.5% national Rx market share and 2–4% regional share within 3–6 months via prescription redirects and PBM flows, boosting near-term revenue per store and foot-traffic monetization. Iron Hill's liquidation removes ~16 local brewpubs and creates immediate asset-sale and lease renegotiation opportunities, favoring deep-pocketed regional restaurateurs or consolidators who can re-open at 20–40% lower capex. Landlord leverage rises—expect downward pressure on small-tenant rents in secondary malls and continued stress on mall anchors (M).

Risk assessment: Tail risks include regulatory intervention on pharmacy consolidation (FTC state-level probes) and PBM reimbursement shocks that could negate captured volume; assign a 10–20% probability over 12 months. Operational risks include prescription-transfer bottlenecks and state Medicaid contract frictions that could delay revenue realization by 1–3 quarters. Key catalysts: bankruptcy auction dates and flu/winter Rx season (next 2–4 months) that will accelerate prescription transfers and reveal true incremental margins.

Trade implications: Tactical: establish a 2–3% long position in CVS equity or a 6-month 10/20% OTM call spread (size 1–2% NAV) to capture expected 3–8% share-price uplift within 3–6 months; hedge with a 6–8% stop. Short Macy’s (M) via 3-month puts ~15% OTM sized 1% NAV or reduce M exposure by 50% given anchor closures and secular mall decline; target 15–25% downside in 3 months. Rotate 20–30% of consumer discretionary exposure into healthcare services and PBM names over next 30 days.

Contrarian angles: The market may underprice the persistent pricing power of local pharmacies—if CVS converts 50–70% of Rite Aid scripts, margin accretion could be 50–150 bps, an outcome the market may underappreciate. Conversely, Macy’s sell-off could be overdone if redevelopments or omnichannel trends unlock asset value; consider buying selective deep OTM calls or REIT-linked shorts as pairs. Event-driven opportunities around Iron Hill auctions (next 30–90 days) can produce >2x returns for asset buyers; monitor auction clearance rates and bid at >40–60% discount to replacement cost.

Key Decisions for Investors

• Establish a 2–3% long position in CVS (CVS) equity within 2 weeks or deploy 1–2% NAV into a 6-month call spread (long 10% OTM / short 20% OTM) to capture expected 3–8% upside from Rx volume reallocation; set a stop-loss at -8% or trim on underperformance after 3 months.
• Initiate a bearish trade on Macy’s (M): buy 3-month puts ~15% OTM sized 1% NAV or short 1–2% position in equity, expecting 15–25% downside over 3 months as anchor closures compress sales; cover on a 10–15% profit or upon positive redevelopment catalysts.
• Reduce consumer-discretionary and regional mall exposure by 20–30% within 30 days and reallocate to healthcare services/PBM names (including increasing CVS exposure) with a 3–12 month holding horizon to capture secular share gains and defensive cash flows.
• Allocate 0.5–1% NAV to event-driven opportunities around Iron Hill asset sales over the next 30–90 days: bid for restaurant assets or buy equities of regional consolidators when assets trade at >40% discount to replacement cost; exit when realized upside >50–100% or within 12 months.
• Before increasing CVS exposure beyond 3% NAV, monitor for regulatory signals (FTC/state AG comments) over the next 30–90 days; if antitrust risk >25% probability (explicit investigations), cap position and prefer long-dated option spreads to limit downside.